Prelude Therapeutics
PRLD
#9185
Rank
A$0.11 B
Marketcap
$2.08
Share price
46.40%
Change (1 day)
-66.44%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$3.26

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.47. In 2022 the company made an earnings per share (EPS) of -$3.90 a decrease over its 2021 EPS that were of -$3.87.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.26-16.37%
2022-$3.900.83%
2021-$3.87-61.3%
2020-$9.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.48 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA